If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Elisabetta Vergani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Melanoma Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
TNF-Related Apoptosis-Inducing Ligand Medicine & Life Sciences
Tumor Microenvironment Medicine & Life Sciences
Exosomes Medicine & Life Sciences
Immunosuppressive Agents Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

  • 89 Citations
  • 3 h-Index
  • 5 Article
  • 1 Review article
3 Citations (Scopus)

Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy

Tuccitto, A., Shahaj, E., Vergani, E., Ferro, S., Huber, V., Rodolfo, M., Castelli, C., Rivoltini, L. & Vallacchi, V., Apr 1 2019, In : Virchows Archiv. 474, 4, p. 407-420 14 p.

Research output: Contribution to journalReview article

Tumor Microenvironment
Immunosuppressive Agents
Neoplasms
Adaptive Immunity
Immunosuppression

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

Huber, V., Vallacchi, V., Fleming, V., Hu, X., Cova, A., Dugo, M., Shahaj, E., Sulsenti, R., Vergani, E., Filipazzi, P., De Laurentiis, A., Lalli, L., Di Guardo, L., Patuzzo, R., Vergani, B., Casiraghi, E., Cossa, M., Gualeni, A., Bollati, V., Arienti, F. & 7 others, De Braud, F., Mariani, L., Villa, A., Altevogt, P., Umansky, V., Rodolfo, M. & Rivoltini, L., Dec 3 2018, In : Journal of Clinical Investigation. 128, 12, p. 5505-5516 12 p.

Research output: Contribution to journalArticle

Myeloid Cells
MicroRNAs
Immunotherapy
Melanoma
Neoplasms
3 Citations (Scopus)
MicroRNAs
Melanoma
Biopsy
Biomarkers
Neoplasms
31 Citations (Scopus)

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

Vergani, E., Di Guardo, L., Dugo, M., Rigoletto, S., Tragni, G., Ruggeri, R., Perrone, F., Tamborini, E., Gloghini, A., Arienti, F., Vergani, B., Deho, P., De Cecco, L., Vallacchi, V., Frati, P., Shahaj, E., Villa, A., Santinami, M., De Braud, F., Rivoltini, L. & 1 others, Rodolfo, M., 2016, In : Oncotarget. 7, 4, p. 4428-4441 14 p.

Research output: Contribution to journalArticle

Melanoma
MicroRNAs
Apoptosis
Cell Proliferation
Cell Line

Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer

Camisaschi, C., Vallacchi, V., Vergani, E., Tazzari, M., Ferro, S., Tuccitto, A., Kuchuk, O., Shahaj, E., Sulsenti, R., Castelli, C., Rodolfo, M., Rivoltini, L. & Huber, V., Nov 4 2016, In : Vaccines. 4, 4

Research output: Contribution to journalArticle

Neoplasms
Tumor Microenvironment
Immunosuppressive Agents
Immunotherapy
Immunity